Found 4 matching trials
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
PHASE2Study Objectives
1. Evaluate the efficacy of the combination of thalidomid...
Location
Weill Medical College of Cornell University
Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma
PHASE2BiRd regimen consisting of clarithromycin and Rd is safe and effective in N...
Location
The First Hospital of Jilin University
BiRd vs. Rd as Initial Therapy in Multiple Myeloma
PHASE3This is a randomized, open-label, phase III study to investigate the effica...
Location
University of Colorado - Anschutz Cancer Center
Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
PHASE3The purpose of this study is to evaluate the safety and efficacy of BiRd re...
Location
The First Affiliated Hospital of Soochow University